BEIJING, May 21, 2021 /PRNewswire/ -- Concord Medical
Services Holdings Limited ("Concord Medical" or the "Company")
(NYSE: CCM), a healthcare provider specializing in cancer care,
research and prevention by operating a network of medically
advanced comprehensive cancer hospitals and standalone radiotherapy
and diagnostic imaging centers in China, today announced changes in its board of
directors (the "Board").
Mr. Denny Lee ("Mr. Lee")
resigned from his position as an independent director of the Board,
the chair of the audit committee and a member of the compensation
committee of the Board. Mr. Qing Pan ("Mr. Pan") resigned from his
position as a director of the Board. Mr. Lee and Mr. Pan have
confirmed that they have no disagreement with the Board. The Board
would like to express its sincere gratitude to Mr. Lee and Mr. Pan
for their contribution during their tenure of service with the
Company.
On May 20, 2021, Mr. Boxun Zhang
("Mr. Zhang") was appointed as an independent director of the
Board, the chair of the audit committee and a member of the
compensation committee of the Board. On the same day, Mr. Yue Yu ("Mr. Yu") was
appointed as a director of the Board.
Mr. Zhang currently serves as the chief investment officer of
Jiaxin Jinhe Investment Management Co., Ltd. From 2014 to 2018, Mr.
Zhang served as the chief financial officer and a director of
Coinage International Co., Limited. Mr. Zhang received his
bachelor's degree in auditing and accounting from Wuhan University in 1998 and a master of
business administration from Cass Business School - City,
University of London in 2004. Mr.
Zhang is an associated member of the Association of International
Accountants.
Mr. Yu currently serves as the chief executive officer and
partner of WisdoMont Asset Management (Shanghai) Co., Ltd. ("WisdoMont"). Since 2014,
he has co-founded WisdoMont, responsible for the establishment of
investment strategy, fund portfolio and risk management. From 2009
to 2013, Mr. Yu served as regional vice president of HSBC Jinxin
Trust. From 2013 to 2014, Mr. Yu served as institutional manager of
GF Fund. With 15 years of experience in the financial industry, Mr.
Yu has extensive experience in institutional business, financial
product design and financing. Mr. Yu received a bachelor's degree
in finance and a master's degree of management from Beijing Normal
University.
About Concord Medical
Concord Medical Services Holdings Limited is a healthcare
provider specialized in cancer treatment, research, education and
prevention. The Company operates a network of medically advanced
comprehensive cancer hospitals and standalone radiotherapy and
diagnostic imaging centers in China. The Company focuses on providing
multidisciplinary cancer care approach in all areas of oncology
services in its cancer hospitals. The Company also equips its
hospitals with technologically advanced equipment such as the
state-of-the-art proton therapy system in its premium cancer
hospitals in top-tier cities including Beijing, Shanghai and Guangzhou. In addition, the Company saw the
opportunity of the expanding market of medical equipment in
China and developed its product
life-cycle management services form its existing medical equipment
and consumable sales services. As of December 31, 2020, the
Company operated a network of 27 radiotherapy centers and
diagnostic imaging centers, which are based in 20 hospitals,
established under long-term lease and management services
arrangements with the Company and spanning over 20 cities across 13
provinces and administrative regions in China. To ensure the
commitment to the highest standard of medical services for
patients, the Company offers ongoing education and training for
doctors and other medical professionals in its network hospitals
and centers in both domestic and overseas medical institutions.
see http://ir.ccm.cn.
Safe Harbor Statement
This announcement contains forward-looking statements. These
forward-looking statements can be identified by words or phrases
such as "will," "expects," "anticipates," "future," "intends,"
"plans," "believes," "estimates" and similar expressions.
Forward-looking statements are inherently subject to uncertainties
and contingencies beyond the Company's control and based upon
premises with respect to future business decisions, which are
subject to change. A number of important factors could cause actual
results to differ materially from those contained in any
forward-looking statement. The Company does not undertake any
obligation to update any forward-looking statement, except as
required under applicable law.
View original
content:http://www.prnewswire.com/news-releases/concord-medical-announces-changes-in-board-of-directors-301296900.html
SOURCE Concord Medical Services Holdings Limited